Search Results 151-160 of 17265 for hba1c

1. Ph 1b Study To Evaluate GSK2110183 In Combination With Bortezomib And Dexamethasone In Subjects With Multiple Myeloma - Mayo Clinic

   HbA1c≤8% at Screening visit; Adequate organ system function as defined in protocol. A female subject is eligible to participate if she is of non ...

2. Study to Evaluate the Effects of Vitamin B3 Derivative on Bone, Skeletal, Muscle and Metabolic Functions in Aging - Mayo Clinic

   Poorly controlled Diabetes Mellitus (HbA1c>8). Clinical History Exclusion Criteria: Confirmed diagnosis of Diabetes Mellitus in use of insulin. Subjects ...

3. Statins and CPAP in Adipose Tissue of OSA - Mayo Clinic

   Fasting glucose > 120 mg/dL and/or HbA1c ≥ 6.5%. Females planning to be pregnant in next six months. Known serious or hypersensitivity to HMG-CoA reductase ...

4. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

   HbA1c =< 7%. Women must not be pregnant or breast-feeding; all females of childbearing potential must have a blood test or urine study within 7 days of ...

5. Feasibility Of Autologous Adipose-derived Stromal Cells From Stromal Vascular Fraction (SVF) To Treat Adults With Pressure Ulcers Or Diabetic Foot Ulcers - Mayo Clinic

   Diabetes. HbA1c < 9. The ability of subjects to give appropriate consent or have an appropriate representative available to do so; The ability of subjects to ...

6. Diabetes care: 10 ways to avoid complications - Mayo Clinic

   This can lead to infections, ulcers that won't heal, and possible removal of one or more limbs, called amputation. Worse blood sugar management. Heart disease.

7. Evaluating Stem Cell Function in Patients with Chronic Kidney Disease (CKD) - Mayo Clinic

   HbA1c ≥ 11%. Subjects on therapeutic doses of anticoagulants [Warfarin (Coumadin), Rivaroxaban (Xarleto); Apixaban (Eliquis); Dabigatran (Pradaxa, Prazaxa)] ...

8. A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease - Mayo Clinic

   The participant has a serum glycosylated hemoglobin (HbA1c) less than 9.5% at the Screening Visit. 5. The participant has a documented clinical diagnosis of ...

9. Evaluation of the Zone-MPC Control Algorithm Integrated into the iAPS in Pregnant Patients with Type 1 Diabetes - Mayo Clinic

   HbA1c ≤ 9%, as performed by point of care or central laboratory testing. A1c will be assessed at the screening visit. Pregnant 140/7 to 326/7 weeks ...

10. Diabetic Retinopathy And Changes In Lipid Metabolism (Protocol AFA) - Mayo Clinic

    ... HbA1c levels < 5.7 as confirmed by the central laboratory, must meet none of the exclusion criteria listed below, and must have no evidence of retinal ...